Combination Therapies: Anti-Obesity Medications and Endoscopic Bariatric Procedures.
Combination therapy
Endoscopic bariatric treatment
Obesity
Pharmacotherapy
Journal
Gastrointestinal endoscopy clinics of North America
ISSN: 1558-1950
Titre abrégé: Gastrointest Endosc Clin N Am
Pays: United States
ID NLM: 9202792
Informations de publication
Date de publication:
Oct 2024
Oct 2024
Historique:
medline:
15
9
2024
pubmed:
15
9
2024
entrez:
14
9
2024
Statut:
ppublish
Résumé
The obesity epidemic continues to worsen in the United States with currently 40% of adults with obesity. While lifestyle changes, pharmacologic and surgical treatments are the mainstay of therapy, they often are either inadequate to meet desired weight loss or underutilized due to patient preference. Endoscopic bariatric treatment can fill these gaps. Combination of endoscopic therapy with pharmacologic therapy can help narrow the gap between endoscopic and surgical bariatric treatment, as well as treat weight recidivism, inadequate weight loss, or further improve associated medical comorbidities in patients who have undergone or are undergoing endoscopic bariatric treatment.
Identifiants
pubmed: 39277302
pii: S1052-5157(24)00056-4
doi: 10.1016/j.giec.2024.06.003
pii:
doi:
Substances chimiques
Anti-Obesity Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
743-756Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have nothing to disclosures.